Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

FIRAS AKHRASS

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1487636205
CMS profile
339152
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$115,682.19

498 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 5 of 10; records 201–250 of 498 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

FIRAS AKHRASS

NPI 1487636205 · CMS profile ID 339152

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 10; records 201–250 of 498 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1487636205?year=2023&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
FIRAS AKHRASS, NPI 1487636205, CMS profile ID 339152. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 10; records 201–250 of 498 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1487636205?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). FIRAS AKHRASS, NPI 1487636205, CMS profile ID 339152. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 10; records 201–250 of 498 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1487636205?year=2023&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
FIRAS AKHRASS, NPI 1487636205, CMS profile ID 339152, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 10; records 201–250 of 498 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1487636205?year=2023&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

498 matching records · $115,682.19 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 498 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 498.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Salix Pharmaceuticals, a division of Bausch Health US, LLC $11.4807/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057160577 CMS
Xeris Pharmaceuticals, Inc. $12.3907/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056459615 CMS
AstraZeneca Pharmaceuticals LP $18.4907/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014317461 CMS
MannKind Corporation $3.2707/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251601 CMS
Novo Nordisk Inc $113.4307/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000198569 CMS
Amgen Inc. $11.4307/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019910051 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $800.0007/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996451197 CMS
Dexcom, Inc. $6.5907/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054955567 CMS
Dexcom, Inc. $127.8907/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054955573 CMS
Novo Nordisk Inc $750.0007/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000198593 CMS
AbbVie Inc. $12.7207/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996106195 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.4607/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996451173 CMS
MannKind Corporation $14.2807/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251595 CMS
Novo Nordisk Inc $10.1507/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000193719 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.3007/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996451177 CMS
Novo Nordisk Inc $5.3207/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000193650 CMS
Abbott Laboratories $23.0107/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018885471 CMS
Lilly USA, LLC $800.0007/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031373247 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.8007/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057428851 CMS
MannKind Corporation $14.2207/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251589 CMS
Lilly USA, LLC $800.0007/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031400641 CMS
Medtronic, Inc. $4.6906/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025777725 CMS
Dexcom, Inc. $13.5106/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054955561 CMS
Novo Nordisk Inc $938.0006/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000198613 CMS
Radius Health, Inc. $8.0106/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1024691661 CMS
Novo Nordisk Inc $9.8106/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000193705 CMS
Novo Nordisk Inc $48.7706/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000198565 CMS
Dexcom, Inc. $130.1606/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054955555 CMS
MannKind Corporation $117.8106/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251585 CMS
Novo Nordisk Inc $15.9506/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000193775 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.4106/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057331331 CMS
MannKind Corporation $38.4106/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251579 CMS
Xeris Pharmaceuticals, Inc. $9.4906/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056459537 CMS
Amgen Inc. $13.0706/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019910049 CMS
MannKind Corporation $3.8406/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251569 CMS
MannKind Corporation $16.4806/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251575 CMS
Abbott Laboratories $20.0606/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1018881795 CMS
Medtronic, Inc. $3.2506/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025777717 CMS
Novartis Pharmaceuticals Corporation $27.5706/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991716819 CMS
Novo Nordisk Inc $750.0006/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000198589 CMS
Tolmar, Inc. $13.5306/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056955425 CMS
MannKind Corporation $22.2906/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056251565 CMS
Medtronic, Inc. $13.4106/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025777709 CMS
Novo Nordisk Inc $750.0006/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000198583 CMS
Corcept Therapeutics $12.1506/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050841939 CMS
Medtronic, Inc. $5.4106/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025777701 CMS
Novo Nordisk Inc $17.2806/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000188345 CMS
Novo Nordisk Inc $4.7706/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000193643 CMS
Kyowa Kirin, Inc. $23.2706/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026995335 CMS
Amgen Inc. $16.2306/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019910057 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $133,840.17 563
PY2020 $75,577.31 441
PY2022 $157,836.39 514
PY2023 $115,682.19 498
PY2024 $134,369.24 505
PY2025 $184,189.32 555

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Principal investigator $98,606.00 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI US SERVICES INC. $5,787.00 10/21/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Added to Metformin in Patients With Type 2 Diabetes Mellitus Who No dispute reported 06/30/2026 691608543
Principal investigator 1 SANOFI US SERVICES INC. $18.00 09/30/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691570389
Principal investigator 1 SANOFI US SERVICES INC. $3,000.00 06/11/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Empagliflozin, and Placebo in Patients With Type 2 Di No dispute reported 06/30/2026 691559087
Principal investigator 1 SANOFI US SERVICES INC. $180.00 06/11/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Empagliflozin, and Placebo in Patients With Type 2 Di No dispute reported 06/30/2026 691559093
Principal investigator 1 SANOFI US SERVICES INC. $472.00 06/11/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Empagliflozin, and Placebo in Patients With Type 2 Di No dispute reported 06/30/2026 691559095
Principal investigator 1 SANOFI US SERVICES INC. $2,881.00 05/23/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691555315
Principal investigator 1 SANOFI US SERVICES INC. $6,616.00 05/09/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691553981
Principal investigator 1 SANOFI US SERVICES INC. $6,739.00 04/25/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691556061
Principal investigator 1 SANOFI US SERVICES INC. $756.00 04/08/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691553929
Principal investigator 1 SANOFI US SERVICES INC. $2,504.00 03/21/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691549869
Principal investigator 1 SANOFI US SERVICES INC. $1,992.00 03/19/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Empagliflozin, and Placebo in Patients With Type 2 Di No dispute reported 06/30/2026 691545609
Principal investigator 1 SANOFI US SERVICES INC. $4,860.00 03/14/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Empagliflozin, and Placebo in Patients With Type 2 Di No dispute reported 06/30/2026 691547831
Principal investigator 1 SANOFI US SERVICES INC. $60,209.00 02/26/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 52-week Randomized, Double-blind, Double-dummy, Active and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Glimepiride or Place No dispute reported 06/30/2026 691546199
Principal investigator 1 SANOFI US SERVICES INC. $2,592.00 01/02/2019 Non-covered Recipient Entity
Erg Holding Company LLC
A 26-week Randomized, Double-blind, Controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Sotagliflozin Compared to Empagliflozin, and Placebo in Patients With Type 2 Di No dispute reported 06/30/2026 691545459